Cargando…
DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
SIMPLE SUMMARY: The DEAD/H-box RNA helicase family is widely involved in tumor progression. Previously, many studies have found that DHX9, DHX15, DDX24, DHX29, etc. are widely involved in tumor progression through various pathways, however, the role of DHX37, as an important member of the DEAD/H-box...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648173/ https://www.ncbi.nlm.nih.gov/pubmed/37958405 http://dx.doi.org/10.3390/cancers15215228 |